The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of palliative care in patients with metastatic esophageal cancer declining chemotherapy.
 
Nicholas Manguso
No Relationships to Disclose
 
Sungjin Kim
No Relationships to Disclose
 
Michelle Guan
No Relationships to Disclose
 
Veronica Placencio-Hickok
Patents, Royalties, Other Intellectual Property - Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst); Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst); Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst); Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst)
 
Haesoo Kim
Stock and Other Ownership Interests - Amgen; Amgen; Amgen; Amgen; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Pfizer; Pfizer; Pfizer; Pfizer
 
Jar-Yee Liu
No Relationships to Disclose
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Perthera; Perthera; Perthera; Perthera
Research Funding - Ipsen; Ipsen; Ipsen; Ipsen
Travel, Accommodations, Expenses - Halozyme; Halozyme; Halozyme; Halozyme
 
Samuel J. Klempner
Stock and Other Ownership Interests - TP Therapeutics; TP Therapeutics; TP Therapeutics; TP Therapeutics
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Lilly; Lilly; Lilly; Lilly
Speakers' Bureau - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst)
 
Miguel Burch
No Relationships to Disclose
 
Alexandra Gangi
No Relationships to Disclose
 
Joseph Chao
Consulting or Advisory Role - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Merck; Merck; Merck; Merck
Research Funding - Brooklyn Immunotherapeutics (Inst); Brooklyn Immunotherapeutics (Inst); Brooklyn Immunotherapeutics (Inst); Brooklyn Immunotherapeutics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novonco Therapeutics (Inst); Novonco Therapeutics (Inst); Novonco Therapeutics (Inst); Novonco Therapeutics (Inst)
 
Mitchell Kamrava
Honoraria - Augmenix; Augmenix; Augmenix; Augmenix; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
Speakers' Bureau - Augmenix; Augmenix; Augmenix; Augmenix
 
Katelyn Mae Atkins
No Relationships to Disclose
 
Jun Gong
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants